Merck's experimental COVID-19 pill cuts hospitalizations, deaths

Merck says its experimental COVID-19 pill cut hospitalizations and deaths by HALF in people recently infected with the virus – and plans to apply for FDA approval Merck’s drug, molnupiravir, stops viruses like the coronavirus from making copies of itself and spreading throughout the body Researchers tracked 775 adults with mild-to-moderate COVID-19 who were considered higher […]